About the company
Nivagen Pharmaceuticals is a developer, manufacturer, and distributor of generic and branded pharmaceuticals headquartered in Sacramento, CA
July 28, 2022
Corbel Capital Partners announced that it has closed a structured investment into Nivagen Pharmaceuticals (the “Company”)
Headquartered in Sacramento, CA, the Company is a specialty pharmaceuticals business that develops and sells generic and branded prescription drugs for the North American market, with an in-house R&D team and laboratory that has built a wide portfolio of complex injectable generics and 505(b)(2) programs. The Company’s management team chose to partner with Corbel given the strategic benefits of having a long-term institutional capital partner with extensive experience and relationships in healthcare and pharmaceutical manufacturing. Corbel’s flexibility and expertise, as well as Corbel’s certainty of close, further demonstrate its ability to effectively partner with talented founders and management teams.
Current Investments
